Table 4.
Bacterial isolates | Number of resistance to antimicrobial agents (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
SXT | AMC | TE | CIP | CN | CRO | AK | AMP | CAZ | CAF | |
E.coli (n = 12) | 04 (33.3) | 3 (25) | 2 (16.7) | 0 (0) | 1 (8.3) | 3 (25) | 0 (0) | 8 (66.7) | 1 (8.3) | 2 (16.7) |
K.pneumoniae (n = 19) | 8 (42.1) | 6 (31.6) | 7 (36.8) | 3 (15. 8) | 3 (15.8) | 15 (78.9) | 2 (10.52) | 18 (94.7) | 2 (10.5) | 6 (31.6) |
Others (n = 08) | 05 (62.5) | 02 (25) | 01 (12.5) | 02 (25) | 01 (12.5) | 04 (50) | 0 (0) | 07 (87.5) | 02 (25) | 02 (25) |
Total = 39 | 17 (43.58) | 11 (28.2) | 10 (25.6) | 5 (12.8) | 5 (12.8) | 22 (56.4) | 2 (5.1) | 33 (84.6%) | 5 (12.8) | 10 (25.6) |
Key: SXT Trimethoprim- sulfamethoxazole, AMC Amoxicillin-clavulanate, TE Tetracycline, Amp Ampicillin, CIP Ciprofloxacin, CN Gentamicin, AK Amikacin, CRO Ceftriaxon, CAZ: Ceftazidamide, CAF Chloramphenicol, Others:Seratiaspecies (01), Enterobactor species (04) and K. rhinose (03)